The global Disposable Hemoperfusion market size is predicted to grow from US$ 1443 million in 2025 to US$ 3082 million in 2031; it is expected to grow at a CAGR of 13.5% from 2025 to 2031.
Hemoperfusion is a treatment technique in which large volumes of the patient"s blood are passed over an adsorbent substance in order to remove toxic substances from the blood. Adsorption is a process in which molecules or particles of one substance are attracted to the surface of a solid material and held there. These solid materials are called sorbents. Disposable Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient"s body. In this report, we calculate medical consumables of hemoperfusion.
China is the largest market with about 48% market share. Followed by Europe and Japan, accounting for about 35% market share.
The key players are Baxter International, Asahi Kasei Corporation, CytoSorbentsCompany 11, Kaneka Pharma, Toray Medical, Aier, Tianjin Zibo High Technology, Biosun Corporation, Kangbei Medical Device, Jafron Biomedical etc. Top 3 companies occupied about 64% revenue market share.
The 鈥淒isposable Hemoperfusion Industry Forecast鈥 looks at past sales and reviews total world Disposable Hemoperfusion sales in 2024, providing a comprehensive analysis by region and market sector of projected Disposable Hemoperfusion sales for 2025 through 2031. With Disposable Hemoperfusion sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Disposable Hemoperfusion industry.
This Insight Report provides a comprehensive analysis of the global Disposable Hemoperfusion landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Disposable Hemoperfusion portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥 unique position in an accelerating global Disposable Hemoperfusion market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Disposable Hemoperfusion and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Disposable Hemoperfusion.
This report presents a comprehensive overview, market shares, and growth opportunities of Disposable Hemoperfusion market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Charcoal Hemoperfusion
Certain Resins Hemoperfusion
Segmentation by Application:
Overdose
Specific Intoxications
Certain Autoimmune Diseases
Hepatic Encephalopathy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Baxter International
Asahi Kasei Corporation
CytoSorbentsCompany 11
Kaneka Pharma
Toray Medical
Aier
Tianjin Zibo High Technology
Biosun Corporation
Kangbei Medical Device
Jafron Biomedical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Disposable Hemoperfusion market?
What factors are driving Disposable Hemoperfusion market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Disposable Hemoperfusion market opportunities vary by end market size?
How does Disposable Hemoperfusion break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Disposable Hemoperfusion Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Disposable Hemoperfusion by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Disposable Hemoperfusion by Country/Region, 2020, 2024 & 2031
2.2 Disposable Hemoperfusion Segment by Type
2.2.1 Charcoal Hemoperfusion
2.2.2 Certain Resins Hemoperfusion
2.3 Disposable Hemoperfusion Sales by Type
2.3.1 Global Disposable Hemoperfusion Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Disposable Hemoperfusion Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Disposable Hemoperfusion Sale Price by Type (2020-2025)
2.4 Disposable Hemoperfusion Segment by Application
2.4.1 Overdose
2.4.2 Specific Intoxications
2.4.3 Certain Autoimmune Diseases
2.4.4 Hepatic Encephalopathy
2.4.5 Others
2.5 Disposable Hemoperfusion Sales by Application
2.5.1 Global Disposable Hemoperfusion Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Disposable Hemoperfusion Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Disposable Hemoperfusion Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Disposable Hemoperfusion Breakdown Data by Company
3.1.1 Global Disposable Hemoperfusion Annual Sales by Company (2020-2025)
3.1.2 Global Disposable Hemoperfusion Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Disposable Hemoperfusion Annual Revenue by Company (2020-2025)
3.2.1 Global Disposable Hemoperfusion Revenue by Company (2020-2025)
3.2.2 Global Disposable Hemoperfusion Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Disposable Hemoperfusion Sale Price by Company
3.4 Key Manufacturers Disposable Hemoperfusion Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Disposable Hemoperfusion Product Location Distribution
3.4.2 Players Disposable Hemoperfusion Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Disposable Hemoperfusion by Geographic Region
4.1 World Historic Disposable Hemoperfusion 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Disposable Hemoperfusion Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Disposable Hemoperfusion Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Disposable Hemoperfusion 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Disposable Hemoperfusion Annual Sales by Country/Region (2020-2025)
4.2.2 Global Disposable Hemoperfusion Annual Revenue by Country/Region (2020-2025)
4.3 Americas Disposable Hemoperfusion Sales Growth
4.4 APAC Disposable Hemoperfusion Sales Growth
4.5 Europe Disposable Hemoperfusion Sales Growth
4.6 Middle East & Africa Disposable Hemoperfusion Sales Growth
5 Americas
5.1 Americas Disposable Hemoperfusion Sales by Country
5.1.1 Americas Disposable Hemoperfusion Sales by Country (2020-2025)
5.1.2 Americas Disposable Hemoperfusion Revenue by Country (2020-2025)
5.2 Americas Disposable Hemoperfusion Sales by Type (2020-2025)
5.3 Americas Disposable Hemoperfusion Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Disposable Hemoperfusion Sales by Region
6.1.1 APAC Disposable Hemoperfusion Sales by Region (2020-2025)
6.1.2 APAC Disposable Hemoperfusion Revenue by Region (2020-2025)
6.2 APAC Disposable Hemoperfusion Sales by Type (2020-2025)
6.3 APAC Disposable Hemoperfusion Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Disposable Hemoperfusion by Country
7.1.1 Europe Disposable Hemoperfusion Sales by Country (2020-2025)
7.1.2 Europe Disposable Hemoperfusion Revenue by Country (2020-2025)
7.2 Europe Disposable Hemoperfusion Sales by Type (2020-2025)
7.3 Europe Disposable Hemoperfusion Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Disposable Hemoperfusion by Country
8.1.1 Middle East & Africa Disposable Hemoperfusion Sales by Country (2020-2025)
8.1.2 Middle East & Africa Disposable Hemoperfusion Revenue by Country (2020-2025)
8.2 Middle East & Africa Disposable Hemoperfusion Sales by Type (2020-2025)
8.3 Middle East & Africa Disposable Hemoperfusion Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Disposable Hemoperfusion
10.3 Manufacturing Process Analysis of Disposable Hemoperfusion
10.4 Industry Chain Structure of Disposable Hemoperfusion
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Disposable Hemoperfusion Distributors
11.3 Disposable Hemoperfusion Customer
12 World Forecast Review for Disposable Hemoperfusion by Geographic Region
12.1 Global Disposable Hemoperfusion 麻豆原创 Size Forecast by Region
12.1.1 Global Disposable Hemoperfusion Forecast by Region (2026-2031)
12.1.2 Global Disposable Hemoperfusion Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Disposable Hemoperfusion Forecast by Type (2026-2031)
12.7 Global Disposable Hemoperfusion Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Baxter International
13.1.1 Baxter International Company Information
13.1.2 Baxter International Disposable Hemoperfusion Product Portfolios and Specifications
13.1.3 Baxter International Disposable Hemoperfusion Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Baxter International Main Business Overview
13.1.5 Baxter International Latest Developments
13.2 Asahi Kasei Corporation
13.2.1 Asahi Kasei Corporation Company Information
13.2.2 Asahi Kasei Corporation Disposable Hemoperfusion Product Portfolios and Specifications
13.2.3 Asahi Kasei Corporation Disposable Hemoperfusion Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Asahi Kasei Corporation Main Business Overview
13.2.5 Asahi Kasei Corporation Latest Developments
13.3 CytoSorbentsCompany 11
13.3.1 CytoSorbentsCompany 11 Company Information
13.3.2 CytoSorbentsCompany 11 Disposable Hemoperfusion Product Portfolios and Specifications
13.3.3 CytoSorbentsCompany 11 Disposable Hemoperfusion Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 CytoSorbentsCompany 11 Main Business Overview
13.3.5 CytoSorbentsCompany 11 Latest Developments
13.4 Kaneka Pharma
13.4.1 Kaneka Pharma Company Information
13.4.2 Kaneka Pharma Disposable Hemoperfusion Product Portfolios and Specifications
13.4.3 Kaneka Pharma Disposable Hemoperfusion Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Kaneka Pharma Main Business Overview
13.4.5 Kaneka Pharma Latest Developments
13.5 Toray Medical
13.5.1 Toray Medical Company Information
13.5.2 Toray Medical Disposable Hemoperfusion Product Portfolios and Specifications
13.5.3 Toray Medical Disposable Hemoperfusion Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Toray Medical Main Business Overview
13.5.5 Toray Medical Latest Developments
13.6 Aier
13.6.1 Aier Company Information
13.6.2 Aier Disposable Hemoperfusion Product Portfolios and Specifications
13.6.3 Aier Disposable Hemoperfusion Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Aier Main Business Overview
13.6.5 Aier Latest Developments
13.7 Tianjin Zibo High Technology
13.7.1 Tianjin Zibo High Technology Company Information
13.7.2 Tianjin Zibo High Technology Disposable Hemoperfusion Product Portfolios and Specifications
13.7.3 Tianjin Zibo High Technology Disposable Hemoperfusion Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Tianjin Zibo High Technology Main Business Overview
13.7.5 Tianjin Zibo High Technology Latest Developments
13.8 Biosun Corporation
13.8.1 Biosun Corporation Company Information
13.8.2 Biosun Corporation Disposable Hemoperfusion Product Portfolios and Specifications
13.8.3 Biosun Corporation Disposable Hemoperfusion Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Biosun Corporation Main Business Overview
13.8.5 Biosun Corporation Latest Developments
13.9 Kangbei Medical Device
13.9.1 Kangbei Medical Device Company Information
13.9.2 Kangbei Medical Device Disposable Hemoperfusion Product Portfolios and Specifications
13.9.3 Kangbei Medical Device Disposable Hemoperfusion Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Kangbei Medical Device Main Business Overview
13.9.5 Kangbei Medical Device Latest Developments
13.10 Jafron Biomedical
13.10.1 Jafron Biomedical Company Information
13.10.2 Jafron Biomedical Disposable Hemoperfusion Product Portfolios and Specifications
13.10.3 Jafron Biomedical Disposable Hemoperfusion Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Jafron Biomedical Main Business Overview
13.10.5 Jafron Biomedical Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.